Breaking Down Xinfengming Group Co., Ltd. Financial Health: Key Insights for Investors

Dive into a focused financial dissection of Xinfengming Group Co., Ltd. (603225.SS): the company posted operating revenue of ¥67.09 billion in 2024 (up 9.15% year‑over‑year) and TTM revenue per share of ¥45.08, while Q1 2025 revenue reached ¥14.56 billion; profitability shows a net income of ¥1.1 billion in 2024 with a TTM net profit margin of 1.69% and ROE at 6.53%, and quarterly EPS of 0.26 yuan (TTM EPS 0.80); on the balance sheet the company carries higher leverage with a debt‑to‑equity ratio of 175.59% and total assets of ¥57.45 billion against liabilities of ¥29.26 billion, yet the market values the firm at a market cap of ¥17.18 billion with a TTM P/E of 14.83, P/S 0.26 and EV/EBITDA 7.90; key growth vectors include PTA capacity expansion (Phase III entering trial production end‑2024 aiming to exceed 10 million tons by end‑2025), over 600 authorized patents, planned Southeast Asia facilities, and a 50% carbon reduction target by 2030-read on for the granular charts, valuation context, leverage implications and risk scenarios that investors need to evaluate.

Xinfengming Group Co., Ltd. (603225.SS) - Revenue Analysis

Key revenue metrics for Xinfengming Group highlight steady top-line expansion and consistent per-share revenue generation across annual, TTM and quarterly horizons. The figures below map the company's recent performance and short-term momentum.

• 2024 total operating revenue: 67.09 billion yuan (up 9.15% from 61.47 billion yuan in 2023).
• Revenue per share (TTM): 45.08 yuan; latest-quarter revenue per share: 8.41 yuan.
• Quarterly revenue growth: 0.70% (most recent quarter).
• TTM revenue growth (period ending Sep 2025 vs same period 2024): 4.47%.
• Q1 2025 revenue: 14.56 billion yuan (vs 14.45 billion yuan in Q1 2024).

• Revenue trajectory: consistent year-over-year growth in 2024 (9.15%) and modest TTM momentum (4.47% through Sep 2025), indicating sustained demand.
• Per-share metrics: TTM and quarterly revenue-per-share figures (45.08 yuan and 8.41 yuan) reflect stable revenue attribution to shareholders.
• Near-term trend: Q1 2025 showed sequential and annual stability (14.56 billion vs 14.45 billion), aligning with low-single-digit TTM growth and small quarterly uptick (0.70%).

For context on corporate direction that may influence future revenue, see: Mission Statement, Vision, & Core Values (2026) of Xinfengming Group Co., Ltd.

Xinfengming Group Co., Ltd. (603225.SS) - Profitability Metrics

• Top-line momentum: 2024 net income reached ¥1.10 billion, a modest 1.32% increase, while Q1 2025 showed sequential improvement to ¥306.7 million from ¥275.17 million a year earlier.
• Margin profile: TTM operating margin of 3.53% vs. net margin of 1.69% indicates a measurable gap between operating profitability and bottom-line conversion (taxes, interest, non-operating items).
• Capital efficiency: TTM ROE of 6.53% signals acceptable returns on equity but room for improvement relative to higher-return peers.
• Shareholder earnings: Quarterly EPS of ¥0.26 and TTM EPS of ¥0.80 reflect steady, if modest, per-share earnings growth aligned with stable net margins.
• Consistency: The company's net profit margin has remained relatively stable, suggesting resilient core operations despite modest growth.

For contextual investor details and shareholder composition, see: Exploring Xinfengming Group Co., Ltd. Investor Profile: Who's Buying and Why?

Xinfengming Group Co., Ltd. (603225.SS) - Debt vs. Equity Structure

Xinfengming Group displays a capital structure tilted toward debt financing, with multiple valuation and leverage metrics that investors should weigh when assessing risk and return.

• Total debt-to-equity ratio: 175.59% - indicates greater reliance on debt than equity.
• Debt-to-equity higher than industry average - more leveraged relative to peers.
• Financial leverage stable - no significant changes observed in recent reporting periods.

Key implications for investors:

• Leverage profile: With a 175.59% debt-to-equity ratio and 29.26 billion CNY in liabilities against 57.45 billion CNY in assets, the balance sheet shows meaningful debt-driven financing.
• Valuation context: EV/Revenue of 0.56 and EV/EBITDA of 7.90 suggest the market prices Xinfengming at a moderate premium to revenue and a mid-range multiple on operating earnings.
• Stability: Reported consistency in financial leverage reduces concern about sudden shifts in capital structure, though the absolute level remains elevated relative to peers.

For broader context on the company's stated strategic direction and values, see: Mission Statement, Vision, & Core Values (2026) of Xinfengming Group Co., Ltd.

Xinfengming Group Co., Ltd. (603225.SS) Liquidity and Solvency

• Current ratio: not specified in available data.
• Quick ratio: not specified in available data.
• Interest coverage ratio: not provided in the available data.
• Cash flow from operations: detailed figures not disclosed in the sources reviewed.
• Solvency ratio: not specified in available data.
• Financial statements examined do not supply granular liquidity and solvency metrics.

• Implication for investors: absence of these metrics increases reliance on primary filings (annual / interim reports) or audited financial statements for rigorous risk assessment.
• Actionable next steps: obtain latest consolidated financial statements, cash flow statements, and notes to compute current ratio, quick ratio, interest coverage, and solvency measures.
• Where to look: company annual report, interim reports, and exchange filings; broker research and financial data providers may fill gaps.

Xinfengming Group Co., Ltd. (603225.SS) - Valuation Analysis

• Relative valuation: TTM P/E of 14.83 sits below the industry average (implying potential undervaluation vs. peers on an earnings basis).
• Asset backing: P/B ~0.94 indicates market pricing close to book value, offering limited downside from tangible equity on a straightforward accounting basis.
• Revenue perspective: P/S of 0.26 signals conservative market pricing of each yuan of sales, which can reflect low margin expectations or a capital-intensive business profile.

• Profitability trends - changes in net margin will directly affect P/E and EV/EBITDA multiple interpretation.
• Revenue growth - sustained top-line growth would justify a higher P/S and EV/Revenue multiple over time.
• Balance sheet shifts - material changes in book value, debt levels, or share count will move P/B and EV-based ratios.

Xinfengming Group Co., Ltd. (603225.SS) - Risk Factors

• Elevated leverage: debt-to-equity ratio at 175.59% signals high financial leverage and limited balance-sheet flexibility.
• Profitability pressure: net profit margin of 1.69% leaves a thin cushion for absorbing adverse sales or cost shocks.
• Interest and refinancing sensitivity: significant reliance on debt financing increases exposure to rising interest rates and maturity-refinancing risk.
• Industry and regulatory risk: operations in the chemical fiber sector expose the firm to environmental regulation, compliance capital expenditure, and potential production curtailments.
• Concentration risk: dependence on a small cohort of large customers or key raw-material suppliers could materially affect revenue or input-costs if relationships shift.
• Cross-border and FX exposure: international operations create geopolitical, trade-policy, and currency-translation risks that can amplify earnings volatility.

Xinfengming Group Co., Ltd. (603225.SS) - Growth Opportunities

Xinfengming Group is positioning for multi-dimensional growth across capacity expansion, product innovation, geographic diversification, and sustainability. Key quantitative targets and initiatives signal potential upside for investors focused on scale, margin enhancement, and ESG-driven demand.

• PTA capacity scale-up: Phase III project entering trial production end-2024, targeting >10 million tonnes total PTA capacity by end-2025.
• New product pipeline: committed to launching at least 10 new products annually, with emphasis on sustainable materials and specialty chemicals.
• International footprint: exports to over 50 countries; plans for two new production facilities in Southeast Asia by 2025 targeting a regional market growing ~12% p.a.
• R&D and IP strength: >600 authorized patents underpinning technological differentiation and higher-margin specialty offerings.
• Green transition: investment in green technologies targeting a 50% reduction in carbon emissions by 2030.

• Near-term growth drivers: Phase III ramp and product commercialization (2024-2025).
• Medium-term tailwinds: Southeast Asia facilities capture ~12% p.a. regional expansion and broadened export base.
• Structural advantages: >600 patents and annual new-product cadence support transition toward higher-margin specialty and sustainable product lines.
• ESG upside: 50% emissions cut by 2030 can unlock investor interest, green financing, and operational efficiencies.

Further context on strategic alignment and corporate ethos: Mission Statement, Vision, & Core Values (2026) of Xinfengming Group Co., Ltd.